{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000613","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2026-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.003142+00:00","generated_at":"2026-05-16T11:36:26.036828+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncotelic completes Tranche 3 of unit offering, raising $1.1M from 22 investors","bullets":["Issued 44 units under final Tranche 3; each unit includes a $25,000 principal, 12% 2-year convertible note.","Each note convertible into 250,000 shares of Oncotelic at $0.10 or 25,000 EdgePoint shares at $1.00.","Each unit includes 250,000 warrants to purchase Oncotelic stock at $0.12 or EdgePoint warrants at $1.25.","Prior 2023 PPM notes settled; existing warrants extended to two years from final closing.","Registration Rights Agreement executed for shares and warrants issued in the financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000613","json":"https://secwatch.observer/filing/0001493152-26-000613.json","markdown":"https://secwatch.observer/filing/0001493152-26-000613.md","text":"https://secwatch.observer/filing/0001493152-26-000613.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/0001493152-26-000613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315226000613/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:36:26.036828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}